World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
72
Citations
38760
World Ranking
19744
National Ranking
795

Francesco Lo-Coco publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Francesco Lo-Coco sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 303 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Francesco Lo-Coco D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Francesco Lo-Coco sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 72 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Francesco Lo-Coco was affiliated with the University of Rome Tor Vergata in Italy. Their research primarily focused on hematology and molecular biology, with significant contributions to the study of acute myeloid leukemia and related hematologic malignancies.

Their main fields of study included:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, notable subfields of study were:

  • Hematology
  • Molecular Biology
  • Genetics
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Francesco Lo-Coco's work covered several key research topics, emphasizing:

  • Acute Myeloid Leukemia Research
  • Retinoids in leukemia and cellular processes
  • Acute Lymphoblastic Leukemia research
  • Epigenetics and DNA Methylation
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Drug-Induced Ocular Toxicity

Frequent coauthors collaborating with Francesco Lo-Coco included:

  • Maria Teresa Voso
  • Miguel Á. Sanz
  • Richard A. Larson
  • Eduardo Magalhães Rego
  • Martin S. Tallman

Publications appeared in various scientific venues, notably:

  • Nature Communications
  • Blood Cancer Journal
  • Blood Advances
  • British Journal of Haematology
  • Cancers

Significant recent papers by Francesco Lo-Coco included:

  • "Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial," 2020, Blood Advances
  • "Genome-wide association study identifies susceptibility loci for acute myeloid leukemia," 2021, Nature Communications
  • "Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters," 2020, British Journal of Haematology
  • "Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants," 2021, Blood Cancer Journal
  • "Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia," 2020, Cancers

Best Publications

  • Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

    Hartmut Döhner;Elihu Estey;David Grimwade;Sergio Amadori

  • Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

    Hartmut Dohner;Elihu H. Estey;Sergio Amadori;Frederick R. Appelbaum

  • Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

    Bruce D. Cheson;John M. Bennett;Kenneth J. Kopecky;Thomas Büchner

  • Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype

    Brunangelo Falini;Christina Mecucci;Enrico Tiacci;Myriam Alcalay

  • Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

    Richard M. Stone;Sumithra J. Mandrekar;Ben L. Sanford;Kristina Laumann

  • Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

    F. Lo-Coco;G. Avvisati;M. Vignetti;C. Thiede

  • Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Miguel A. Sanz;David Grimwade;Martin S. Tallman;Bob Lowenberg

  • Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations

    Jlenia Guarnerio;Marco Bezzi;Jong Cheol Jeong;Stella V. Paffenholz

  • The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.

    Min Sup Song;Leonardo Salmena;Arkaitz Carracedo;Ainara Egia

  • Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

    Miguel A. Sanz;Miguel A. Sanz;Pierre Fenaux;Martin S. Tallman;Elihu H. Estey

  • Epigenetic Silencing of the Myelopoiesis Regulator microRNA-223 by the AML1/ETO Oncoprotein

    Francesco Fazi;Serena Racanicchi;Giuseppe Zardo;Giuseppe Zardo;Linda M. Starnes;Linda M. Starnes

  • Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.

    Uwe Platzbecker;Giuseppe Avvisati;Laura Cicconi;Christian Thiede

  • Retinoic acid receptors: from molecular mechanisms to cancer therapy.

    Alessandra di Masi;Loris Leboffe;Elisabetta De Marinis;Francesca Pagano

  • Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

    Francesco Lo-Coco;Giuseppe Avvisati;Marco Vignetti;Massimo Breccia

  • Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy

    David Grimwade;Jelena V. Jovanovic;Robert Kerrin Hills;Elizabeth A. Nugent

  • Elevated expression of IL-3Rα in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis

    Ugo Testa;Ugo Testa;Ugo Testa;Roberta Riccioni;Roberta Riccioni;Roberta Riccioni;Stefania Militi;Stefania Militi;Stefania Militi;Eliana Coccia;Eliana Coccia;Eliana Coccia

  • Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia

    Francesco Buccisano;Luca Maurillo;Maria Ilaria Del Principe;Giovanni Del Poeta

  • Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia.

    Alessandro M. Vannucchi;Elisabetta Antonioli;Paola Guglielmelli;Alessandro Pancrazzi

  • Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia

    Francesco Lo-Coco;Giuseppe Cimino;Massimo Breccia;Nélida I. Noguera

  • Active Pin1 is a key target of all- trans retinoic acid in acute promyelocytic leukemia and breast cancer

    Shuo Wei;Shingo Kozono;Lev Kats;Morris Nechama

Frequent Co-Authors

Miguel A. Sanz
Miguel A. Sanz University of Valencia
Sergio Amadori
Sergio Amadori University of Rome Tor Vergata
Martin S. Tallman
Martin S. Tallman Northwestern University
David Grimwade
David Grimwade King's College London
Arnold Ganser
Arnold Ganser Hannover Medical School
Bob Löwenberg
Bob Löwenberg Erasmus MC
Pier Giuseppe Pelicci
Pier Giuseppe Pelicci European Institute of Oncology
Hartmut Döhner
Hartmut Döhner University of Ulm
Franco Mandelli
Franco Mandelli Sapienza University of Rome
Raul C. Ribeiro
Raul C. Ribeiro St. Jude Children's Research Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medical careers or related fields, online education offers flexible options that can enhance qualifications and open new career pathways. Choosing an accredited and reputable program is essential for ensuring your degree is recognized by employers and professional boards.

Healthcare management is increasingly popular, allowing students to prepare for roles in hospitals, clinics, and public health organizations. Explore online health administration programs if you’re interested in the business and operational side of healthcare systems.

Nurses seeking to advance into practitioner roles can consider rn to np programs, which streamline the path from registered nurse to nurse practitioner and offer both clinical and leadership opportunities.

Nutrition is also a growing field, and earning an online degree nutrition can provide foundational science knowledge, making graduates eligible for diverse roles in wellness, public health, and dietary counseling.

For those aiming for higher-level administration, accredited accredited mha programs help professionals prepare for executive leadership roles in healthcare institutions.

Best Scientists Citing Francesco Lo-Coco

Recently Published Articles